ENDRA Life Sciences Inc. [NDRA] - / ASP Isotopes Inc. merger
ENDRA Life Sciences Inc. has entered into a definitive merger agreement with ASP Isotopes Inc., which includes Kruger Merger Sub LLC and Renergen Limited, effective October 1, 2026.
Why this matters
ENDRA Life Sciences Inc., a company operating in the electromedical and electrotherapeutic apparatus industry, has entered into a definitive merger agreement with ASP Isotopes Inc., effective October 1, 2026. This merger involves several entities, including Kruger Merger Sub LLC and Renergen Limited, and represents a strategic consolidation within the sector. The agreement, initially made on June 25, 2026, has been amended to allow certain financial arrangements, such as an addendum to a term loan facility, indicating a focus on financial structuring as part of the merger process.